Assessing the Utility of the HEART Score in the Era of High-Sensitivity Troponin

Ethan F Kramer1, Jonathan Van Name1,2, Rogina Rezk1

  • 1From the College of Medicine, University of Florida, Gainesville, FL.

PubMed

Insights

High-sensitivity troponin I (Hs-TnI) effectively rules out major adverse cardiac events (MACE) in emergency department patients with moderate or high HEART scores. A low Hs-TnI level indicates a very low risk of cardiac events, aiding clinical decisions.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Biomarkers

Background:

  • The HEART score is used to assess cardiovascular risk in patients with chest pain.
  • Older troponin assays limit the HEART score's clinical utility.
  • High-sensitivity troponin I (Hs-TnI) offers improved diagnostic accuracy.

Purpose of the Study:

  • To evaluate if Hs-TnI alone can stratify cardiovascular risk in patients with moderate or high HEART scores.
  • To determine the negative predictive value (NPV) of Hs-TnI in ruling out major adverse cardiac events (MACE).

Main Methods:

  • Analysis of management and outcomes in adult patients presenting to the ED with chest pain.
  • Inclusion criteria: moderate or high HEART score and Hs-TnI below the 99th percentile.
  • Calculation of 30-day MACE incidence and NPV of Hs-TnI.

Main Results:

  • The study included 1331 patients with moderate (92.0%) or high (8.0%) HEART scores.
  • The 30-day incidence of MACE was low at 0.2%.
  • Hs-TnI below the 99th percentile demonstrated a 99.8% NPV for ruling out MACE.

Conclusions:

  • Hs-TnI is a reliable biomarker for excluding MACE in patients with moderate or high HEART scores.
  • A moderate or high HEART score alone should not dictate admission if Hs-TnI is not elevated.
  • Hs-TnI can refine risk stratification, potentially reducing unnecessary hospital admissions.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
334
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
72
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
119
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
117
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
213